Table 3 Mortality outcomes
Location | Follow-up study | Deaths in control groupa | Livebirths in control group | Deaths in intervention groupa | Livebirths in MMN group | Mortality differencea MMN – control, per 1000 livebirths (95 % CI) |
|---|---|---|---|---|---|---|
Bangladesh, JiVitA | West et al. [26] | 764 625 neonatal 139 at 29–180 days | 14,142 | 741 626 neonatal 115 at 29–180 days | 14,374 | –2.5 (–8.1 to 3.1)b |
Bangladesh, MINIMat | Persson et al. [27] | 33 23 neonatal 10 post-neonatal to 5 years | 612 | 34 25 neonatal 9 post-neonatal to 5 years | 595 | 3.2 (–22.6 to 29.0) |
Burkina Faso | Roberfroid et al. [35] | 45 7 neonatal 38 post-neonatal to 30 months | 644 | 55 11 neonatal 44 post-neonatal to 30 months | 650 | 14.7 (–14.3 to 43.8) |
Chinac | Wang et al. [41] | 16 16 neonatal 0 in children born in 2004 | 1499 | 20 18 neonatal 2 in children born in 2004 | 1469 | 6.10 (–3.9 to 17.3)b |
Guinea Bissau | Andersen et al. [36] | 57 25 neonatal 9 at 29–91 days 10 at 92–365 days 13 at 366–730 days | 519 | 65 29 neonatal 6 at 29–91 days 21 at 92–365 days 9 at 366–730 days | 528 | 13.3 (–25.8 to 52.4) |
Indonesiac | Prado et al. [37] | 580 infant 17 in subsample | 14,053 | 490 infant 12 in subsample | 14,373 | –13.2 (–33.4 to 7.1)b |
Mexicoc | Ramakrishnan et al. [38] | 7 6 early deaths 1 in control group of childhood randomisation | 460 | 4 4 early deaths | 456 | –10.30 (–29.30 to 6.60) |
Nepal Janakpur | Devakumar et al. [39] | 22 12 neonatal 6 post-neonatal 4 at 1–8 years | 564 | 23 17 neonatal 4 post-neonatal 2 at 1–8 years | 567 | 1.6 (–21.2 to 24.3) |
Nepal Sarlahi | Christian et al. [40] | 54 34 before 91 days 20 at 91 days to 7 years | 773 | 81 52 before 91 days 29 at 91 days to 7 years | 872 | 23.0 (–5.2 to 51.3)b |